Disease activity and therapeutic response to pegcetacoplan for geographic atrophy identified by deep learning-based analysis of OCT

Macular DiseasesRetinal Diseases

Ocular Adverse Events Associated with Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Population-Based Pharmacovigilance Study: Ocular Adverse Events of Pegcetacoplan & Avacincaptad Pegol

Am J Ophthalmol

Kailani Z, Mihalache A, Popovic MM, Kertes PJ, Muni RH

doi: 10.1016/j.ajo.2025.04.022

Retinal Diseases

Progression rate of macular retinal pigment epithelium atrophy in geographic atrophy and selected inherited retinal dystrophies. A systematic review and meta-analysis

Am J Ophthalmol

Bassil FL, Colijn JM, Thiadens AAHJ, Biarnés M

doi: 10.1016/j.ajo.2024.07.035

Macular DiseasesFurther Publications

Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study

Ophthalmol Sci

Mulyukov Z, Keane PA, Sahni J, Liakopoulos S, Hatz K, Wei Ting DS, Gallego-Pinazo R, Aslam T, Gemmy Cheung CM, De Salvo G, Semoun O, Somfai GM, Stahl A, Lujan BJ, Lorand D

doi: 10.1016/j.xops.2024.100565

Glaucoma and Ocular Pressure

OCT-based diagnosis of glaucoma and glaucoma stages using explainable machine learning

Sci Rep

Hasan MM, Phu J, Wang H, Sowmya A, Kalloniatis M, Meijering E

doi: 10.1038/s41598-025-87219-w

Macular Diseases

Cross-instrument optical coherence tomography-angiography (OCTA)-based prediction of age-related macular degeneration (AMD) disease activity using artificial intelligence

Sci Rep

Heinke A, Zhang H, Broniarek K, Michalska-Małecka K, Elsner W, Galang CMB, Deussen DN, Warter A, Kalaw F, Nagel I, Agnihotri A, Mehta NN, Klaas JE, Schmelter V, Kozak I, Baxter SL, Bartsch DU, Cheng L, An C, Nguyen T, Freeman WR

doi: 10.1038/s41598-024-78327-0

Retinal Diseases

Three-Year Clinical Outcomes in Geographic Atrophy: An Analysis of 18,712 Patient Eyes

Retina

Shughoury A, Boucher N, Aggarwal N, Ciulla TA

doi: 10.1097/IAE.0000000000004285

Retinal Diseases

Systematic Review and Meta-Analysis of OCT measurements in patients with chronic kidney disease

Retina

Bineshfar N, Changizi F, Farjam M, Sharafi F, Williams BK Jr

doi: 10.1097/IAE.0000000000004377

Macular Diseases

Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From The Phase 3 Oaks Trial: Microperimetry: Visual Function Benefit With Pegcetacoplan

Am J Ophthalmol

Chakravarthy U, Schwartz R, Guymer RH, Holz FG, Rachitskaya AV, Vujosevic S, Lewis P, Vorwerk H, Alibhai AY, Moult EM, Morales MU, Bliss C, Baumal CR, Waheed NK

doi: 10.1016/j.ajo.2025.02.012

Retinal Diseases

Integration of Proteomics and Artificial Intelligence-Driven OCT Biomarker Analysis in Central Vein Retinal Occlusion

Exp Eye Res

Desideri LF, Kojima K, Eldridge N, Zysset-Burri DC, Ørskov M, Vorum H, Honoré B, Zinkernagel MS, Cehofski LJ

doi: 10.1016/j.exer.2025.110462

Related content

Ocular Adverse Events Associated with Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Population-Based Pharmacovigilance Study: Ocular Adverse Events of Pegcetacoplan & Avacincaptad Pegol

Progression rate of macular retinal pigment epithelium atrophy in geographic atrophy and selected inherited retinal dystrophies. A systematic review and meta-analysis

Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study

OCT-based diagnosis of glaucoma and glaucoma stages using explainable machine learning

Cross-instrument optical coherence tomography-angiography (OCTA)-based prediction of age-related macular degeneration (AMD) disease activity using artificial intelligence

Three-Year Clinical Outcomes in Geographic Atrophy: An Analysis of 18,712 Patient Eyes

Systematic Review and Meta-Analysis of OCT measurements in patients with chronic kidney disease

Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From The Phase 3 Oaks Trial: Microperimetry: Visual Function Benefit With Pegcetacoplan

Integration of Proteomics and Artificial Intelligence-Driven OCT Biomarker Analysis in Central Vein Retinal Occlusion